This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Next Generation Protein Therapeutics Summit

$700 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
September 28-30, 2022
Boston Convention and Exhibition Center

Fredrik Frejd, Ph.D.
Chief Scientific Officer at Affibody AB


Prof. Frejd has over fifteen years of experience in life science research with particular expertise in tumor biology, phage display and therapeutic protein engineering of antibody fragments and alternative scaffolds. He joined Affibody AB in 2002. Dr. Frejd is an adjunct professor at the unit for Biomedical radiation sciences, Uppsala University.

Agenda Sessions

  • Affibody Technology Based Formats in Clinical Development and Future Outlook


Speakers at this event